Ardelyx (ARDX) EBIT Margin (QoQ) (2013 - 2026)
Ardelyx (ARDX) EBIT Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,878.00 |
| Dec 31, 2025 | -13,322.00 |
| Sep 30, 2025 | 15,203.00 |
| Jun 30, 2025 | 3,431.00 |
| Mar 31, 2025 | -5,604.00 |
| Dec 31, 2024 | 472.00 |
| Sep 30, 2024 | 2,089.00 |
| Jun 30, 2024 | 3,501.00 |
| Mar 31, 2024 | 2,782.00 |
| Dec 31, 2023 | -9,456.00 |
| Sep 30, 2023 | 8,756.00 |
| Jun 30, 2023 | 15,482.00 |
| Mar 31, 2023 | -25,674.00 |
| Dec 31, 2022 | 46,632.00 |
| Sep 30, 2022 | 59,898.00 |
| Jun 30, 2022 | 490,386.00 |
| Mar 31, 2022 | -251,378.00 |
| Dec 31, 2021 | 17,279.00 |
| Sep 30, 2021 | -18,621.00 |
| Jun 30, 2021 | -292,822.00 |